BHRT: Hormones Are Not an Afterthought in Mental Health
Estradiol, testosterone, progesterone, and DHEA are not just reproductive hormones. Each has a direct, measurable role in brain chemistry, including serotonin and dopamine signaling, the brain's growth-factor system (BDNF), and the stress-response axis. When they drop or fall out of balance, whether from perimenopause, andropause, chronic stress, or another cause, the effect on mood and cognition can be as real as any other biological driver of depression or anxiety.
At Peak Body and Mind, bioidentical hormone optimization is evaluated and dosed from your actual labs and your response over time, as one part of a broader, individualized plan.
"A patient can spend years cycling through medications without anyone ever drawing the labs that would show whether a hormonal deficit was contributing the whole time. That gap is exactly what this evaluation is built to close."

The Problem:

Why This Often Gets Missed
Estradiol, testosterone, progesterone, and DHEA are rarely part of a routine psychiatric intake. Most people are never asked whether their depression or anxiety might be hormonally driven before starting standard treatment, so a hormonal contributor can go unmeasured for years.
The Approach:

Measured First, Dosed to You
Hormone levels are measured directly through blood labs before any hormone is started, then rechecked periodically to guide dosing. We use bioidentical, compounded formulations only, at the lowest effective dose to reach a healthy physiologic range, never fixed or one-size-fits-all dosing.
What This Is Not:

Not Synthetic, Not Assumed, Not Stand-Alone
Not synthetic hormone therapy, not started without baseline labs, and not a stand-alone treatment. Hormone optimization is one part of a broader plan, introduced once labs confirm a relevant deficit.
Several hormones have direct, well-documented effects on brain chemistry
Estradiol
Reduces MAO-A activity (the enzyme that breaks down serotonin, dopamine, and norepinephrine), activates the BDNF gene to support adaptive brain change, and helps restore serotonin-receptor density so the brain can respond to the serotonin it has.
Testosterone
Acts on a distinct gene-regulatory site to support BDNF production, and supports dopamine-system activity tied to motivation and the loss of interest or pleasure seen
in depression.
Progesterone
Converts in the body to allopregnanolone, a neurosteroid that acts on the GABA-A receptor, the brain's primary calming system. This is the same neurosteroid mechanism validated at the highest regulatory level by FDA-approved medications for postpartum depression.
DHEA
Acts as a neurosteroid with documented antidepressant and neuroprotective properties, and serves as a biomarker of the stress-response system's resilience.
You Might Have A Hormonal Driver If...
You are a woman in your late 30s to 50s with new or worsening anxiety, depression, or irritability that your life circumstances don't explain.
Your mood, sleep, or anxiety tracks with your menstrual cycle, or shifted after childbirth and never fully settled.
You are a man feeling burnt-out, flat, and unmotivated, with fatigue, low libido, or brain fog that doesn't match your effort to rest.
You got a partial response at best from standard antidepressant or anti-anxiety treatment, and no one ever measured your hormone levels.
Your symptoms started or worsened around a hormonal transition (perimenopause, postpartum, andropause) rather than a clear psychological trigger.
This doesn't mean your symptoms are "just hormonal." It means a hormonal contributor is common enough, and treatable enough, that it deserves to be ruled in or out with real lab work, not ruled out by assumption.
How BHRT Works In Practice
F.A.Q.
Bioidentical hormones are molecularly identical to what your body produces. Synthetic hormones and synthetic progestins have a different molecular structure. We use bioidentical, compounded formulations exclusively.
Yes. Hormone levels (estradiol, testosterone, progesterone, DHEA-S, and related markers) are measured before any hormone is started, and rechecked periodically afterward.
It overlaps with that broader category, but our approach is specifically about identifying a lab-confirmed hormonal contributor to a mental-health symptom, dosed individually and monitored closely, not a generic, one-size-fits-all replacement.
No. It is layered alongside the rest of your individualized plan where lab work supports it, not used as a stand-alone approach.
It varies by hormone and by individual. Some people notice changes within weeks; a full assessment of benefit usually involves rechecking labs and symptom scales over months, not a single visit.
It may, when lab work confirms a hormonal contributor to your symptoms. We consider it most often for depression tied to perimenopause or low testosterone, anxiety with a hormonal component (including perimenopausal and premenstrual anxiety), and postpartum depression or PTSD, where stress- and reproductive-hormone systems are frequently and measurably disrupted. An evaluation and baseline labs tell us whether it fits your case.
THE EVIDENCE
Several independent, high-quality trials support hormone-sensitive brain biology in specific conditions
Perimenopausal depression
A randomized, double-blind, placebo-controlled trial of transdermal estradiol found a 68 percent remission rate versus 20 percent on placebo (Soares 2001). A separate Harvard-led study found that it is estradiol instability and the absence of ovulatory progesterone, not simply low estradiol, that most closely track with mood (Joffe 2020), which is why we look at hormone pattern, not just a single number.
Major depressive disorder
A randomized, placebo-controlled trial of DHEA found a significantly greater reduction in depression ratings than placebo (Wolkowitz 1999).
Hypogonadal older men
A large, multi-site, placebo-controlled testosterone trial found modest mood improvement, alongside more substantial gains in sexual function, vitality, and bone density (Snyder 2016).
Postpartum
depression
Phase 3 trials of an allopregnanolone-based medication (progesterone's active neurosteroid metabolite) produced rapid reductions in depression severity, the basis of the first FDA-approved medication for postpartum depression (Meltzer-Brody 2018).
Honest calibration:
A 2026 systematic review of hormone therapy in younger menopausal women found inconsistent evidence for a mood or cognition benefit across the broader body of trials (Bencivenga 2026). The strongest evidence is in the specific, lab-confirmed situations above, which is exactly why we start with labs and target treatment rather than applying hormones broadly.

Josh Swigart, APRN, PMHNP-BC. Measurement-informed, biology-first psychiatry.
Josh Swigart, APRN, PMHNP-BC. Regenerative Psychiatry, Neuroplasticity, Cognitive Performance Medicine. KRI Fellow, A4M ABAAHP Fellow-in-Training, Triple Certified Peptide Therapy, Advanced IVNT Certified, Double Certified Neural Therapy, Koniver Method Clinician.

Rule it in, or rule it out, with real lab work
Hormonal contributors to anxiety, depression, and cognitive symptoms are common and frequently overlooked. If this sounds like your experience, it is worth finding out with real lab work rather than continuing to guess.

References
This page is educational and is not a diagnosis or a substitute for individualized medical advice. If you are in crisis, call or text 988, call 911, or go to your nearest emergency department.